international collaborations
The Alliance International Collaborations (IC) oversees the operational activities of international sites (full member and non-member collaborators) that participate in Alliance trials. The goal of the Alliance IC is to support high quality, collaborative research with international groups by helping facilitate and guide international sites through the logistical discussions required for study activation. To learn more about international collaborations at the Alliance, or if you have questions, please contact international@alliancenctn.org.
Active Alliance Trials with International Collaborations
Alliance A031102 - Randomized phase III trial comparing conventional-dose chemotherapy using paclitaxel, ifosfamide, and cisplatin (TIP) with high-dose chemotherapy using mobilizing paclitaxel plus ifosfamide followed by high-dose carboplatin and etoposide (TI-CE) as first salvage treatment in relapsed or refractory germ cell tumors
Alliance N1048 - Phase II/II trial of neoadjuvant FOLFOX, with selective use of combined modality chemoradiation versus preoperative combined modality chemoradiation for locally advanced rectal cancer patients undergoing low anterior resection with total mesorectal excision
Alliance N0577 - Phase III intergroup study of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy with adjuvant PCV chemotherapy in patients with 1p/19q co-deleted anaplastic glioma or low grade glioma
Resource Links
For information regarding investigator registration, please visit the NCI Investigator Resources website.
For information about obtaining Federal Wide Assurance, please visit the OHRP website.
